Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

ShRNA profiling of human DZNep-treated glioblastoma multiforme cancer stem cells


ABSTRACT: Overexpression of the Polycomb group protein Enhancer of Zeste Homolog 2 (EZH2) occurs in diverse malignancies, including prostate cancer, breast cancer, and glioblastoma multiforme (GBM) (1). Based on its ability to modulate transcription of key genes implicated in cell cycle control, DNA repair and cell differentiation, EZH2 is believed to play a crucial role in tissue-specific stem cell maintenance and tumor development. Here we show that targeted pharmacologic disruption of EZH2 by the S-adenosylhomocysteine hydrolase inhibitor 3-Deazaneplanocin A (DZNep), or its specific down-regulation by shRNA, strongly impairs GBM cancer stem cell self-renewal in vitro and tumor-initiating capacity in vivo. Using genome-wide expression analysis of DZNep-treated GBM cancer stem cells, we found the expression of c-myc, recently reported to be essential for GBM cancer stem cells, to be strongly repressed upon EZH2 depletion. Specific shRNA-mediated down-regulation of EZH2 in combination with chromatin immunoprecipitation (ChIP) experiments revealed that c-myc is a direct target of EZH2 in GBM cancer stem cells. Taken together, our observations provide evidence that direct transcriptional regulation of c-myc by EZH2 may constitute a novel mechanism underlying GBM cancer stem cell maintenance and suggest that EZH2 may be a valuable new therapeutic target for GBM management. Experiment Overall Design: Three samples of cancer stem-cell enriched gliospheres from primary glioblastoma multiforme cell cultures were treated with DZNep. Untreated gliospheres from the same cultures were used as controls.

ORGANISM(S): Homo sapiens

SUBMITTER: Paolo Provero 

PROVIDER: E-GEOD-18150 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2009-11-30 | GSE18150 | GEO
| PRJNA119483 | ENA
| phs000505 | dbGaP
| 2185625 | ecrin-mdr-crc
2024-01-26 | PXD043557 | Pride
2009-01-13 | E-MEXP-1330 | biostudies-arrayexpress
2024-09-02 | BIOMD0000000757 | BioModels
2023-06-01 | E-MTAB-12473 | biostudies-arrayexpress
2021-12-01 | GSE179667 | GEO
2009-04-11 | E-GEOD-11100 | biostudies-arrayexpress